4.5 Article

Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study

Journal

ENDOCRINE PRACTICE
Volume 27, Issue 4, Pages 326-333

Publisher

ELSEVIER INC
DOI: 10.1016/j.eprac.2020.10.016

Keywords

captopril challenge test; comparison; diagnostic accuracy; primary aldosteronism; seated saline suppression test

Funding

  1. National Natural Science Foundation of China [81670785, 81800701, 81870567, 81800731, 81970720]
  2. National Key Research & Development Plan, Major Project of Precision Medicine Research [2017YFC0909600]
  3. Chongqing Science and Technology Committee Innovation Project (Technology Development and Application of Precision Medicine) [cstc2016shms-ztzx1003]
  4. Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission [2018QNXM001]
  5. Outstanding Talents of the First Affiliated Hospital of Chongqing Medical University 2019 [2019-4-22]
  6. Chongqing Outstanding Youth Funds [cstc2019jcyjjq0006]

Ask authors/readers for more resources

In hypertensive patients at high risk for primary aldosteronism, seated saline suppression test (SSST) and captopril challenge test (CCT) showed comparable diagnostic accuracy. While insufficient sodium intake decreases the efficiency of SSST, it does not affect CCT. Due to its simplicity and cost-effectiveness, CCT is preferred over SSST.
Objective: The saline suppression test (SST) and captopril challenge test (CCT) are commonly used confirmatory tests for primary aldosteronism (PA). Seated SST (SSST) has been reported to be superior to recumbent SST. Whether SSST is better than CCT remains unclear. We aimed to compare the diagnostic accuracy of SSST and CCT in a prospective study. Methods: Hypertensive patients at a high risk of PA were consecutively included. Patients with an aldosterone-renin ratio of >= 1.0 ng/dL/mu IU/mL were asked to complete SSST, CCT, and the fludrocortisone suppression test (FST). Using FST as a reference standard (plasma aldosterone concentration [PAC] post FST >= 6.0 ng/dL), area under the receiver-operating characteristic curve (AUC), sensitivity, and specificity of SSST and CCT were calculated, and multiple regression analyses were performed to identify potential factors leading to false diagnosis. Results: A total of 196 patients diagnosed with PA and 73 with essential hypertension completed the study. Using PAC post SSST and PAC post CCT to confirm PA, SSST and CCT had comparable AUCs (AUC(SSST) 0.87 [95% CI 0.82-0.91] vs AUC(CCT) 0.88 [0.83-0.95], P = .646). When PAC post SSST and post CCT were set at 8.5 and 11 ng/dL, respectively, the sensitivity and specificity of SSST (0.72 [0.65, 0.78] and 0.86 [0.76, 0.93]) and CCT (0.73 [0.67, 0.80] and 0.85 [0.75, 0.92]) were not significantly different. In the multiple regression analyses, 1-SD increment of sodium intake resulted in a 40% lower risk of false diagnosis with SSST. Conclusion: SSST and CCT have comparable diagnostic accuracy. Insufficient sodium intake decreases the diagnostic efficiency of SSST but not of CCT. Since CCT is simpler and cheaper, it is preferred over SSST. (C) 2020 AACE. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available